VT Finance AG

BB MEDTECH AG (information about investment rationale) was established as an investment company in Schaffhausen (Switzerland) in November 1995. BB MEDTECH’s principal focus is investing in both public and private companies within the global medical technology industry.

The fundamentals of the medical technology industry appear uniquely attractive given the relatively consistent secular growth prospects of roughly 8-10 percent per annum. Growth is driven by a number of factors including demographics, geographic market expansion and the flow of innovative new products that address still numerous unmet medical needs. The number of people who are older than 65 years increases at a rate of about 1 million per month.

BB MEDTECH affords shareholders the opportunity to selectively invest in companies and technologies in the global medical technology industry. The team of physicians, scientists and financial professionals at Swissfirst Asset Management, with the assistance of a global network of external industry consultants, dutifully pursue on behalf of the board of directors of BB MEDTECH the best investment opportunities the industry has to offer. Based on extensive fundamental research, investment recommendations are made to and decided by the board of directors. The board consists of very knowledgeable and accomplished experts in the fields of medical technology and biotechnology that look for companies that offer one of more of the following: strong management teams, breakthrough technology platforms, global franchises in particular therapeutic opportunities and attractive financial structures. As a result, the portfolio generally has 3 to 4 core positions and up to 10 smaller equity investments. Up to 10 percent of the portfolio may be invested in non-listed companies. BB MEDTECH strives to offer relatively consistant, above-average investment returns for its shareholders.